Clinical Trial Update: Effect of Hyperthyroidism and Its Treatment in Graves' Disease to Early Marker of Atherosclerosis [Phase 3]

View source ↗

Summary

Phase 3 trial update examining the effect of hyperthyroidism and its treatment on an early marker of atherosclerosis in Graves' disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Graves Disease
• Hyperthyroidism

Snippet

Sponsor: Indonesia University | Conditions: Hyperthyroidism, Graves Disease | Phase 3 | Status: COMPLETED